EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prenatal Spina Bifida Repair: Defendable Trespassing of MOMS Criteria Results in Commendable Personalized Medicine

Ueli Moehrlen, Nicole Ochsenbein-Kölble, Sarah Stricker, Theres Moehrlen, Luca Mazzone, Franziska Krähenmann, Ladina Vonzun, Roland Zimmermann, Spina Bifida Study Group Zurich, Martin Meuli

Fetal Diagnosis and Therapy · 2023

DOI: 10.1159/000533181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2023. Verfasst von Ueli Moehrlen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Meningomyelocele, Spinal Dysraphism, Spina Bifida Cystica. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We hypothesize that after publication of the quintessence of the MOMS trial, eligibility criteria for prenatal spina bifida (SB) repair may be modified if a tenable argumentation underlies this decision.

Methods

Our first 154 fetal surgery patients were analyzed with particular focus on how many, which, and why the original eligibility criteria, set forth by the MOMS Trial Protocol, were disobeyed, and what the eventually detectable, negative and positive impacts of these deviations on outcomes were.

Results

A total of 152 patients (2 missing consent) were included (100%). In 69 patients (45.4%), a total of 89 eligibility criteria were disobeyed. In 54 (35.6%) cases, the following maternal criteria were concerned: gestational age at operation of >25+6 weeks in 17 (11.2%), uterine pathologies in 13 (8.6%) women, preoperative BMI ≥35 kg/m2 in 12 (7.9%), previous hysterotomy in 7 (4.6%), previous prematurity in 3 (2%), HIV/hepatitis B in 2 (1.3%), psychosocial issues in 2 (1.3%), and placenta praevia in 1 (0.7%). In 32 (21.1%) cases, fetal criteria were disobeyed 34 times: Fetal anomaly unrelated to SB in 19 (12.5%), no/minimal evidence of hindbrain herniation in 13 (8.6%), and severe kyphosis in 2 (1.3%). We could not identify cases where non-observation of criteria led to clear-cut maternal and/or fetal disadvantages.

Conclusion

This study shows that MOMS trial eligibility criteria for prenatal SB repair should be modified or even abandoned with adequate medical and ethical argumentation, and with written parental informed consent after non-directive, full disclosure counseling. This clear-cut change of paradigm is a necessity as it leads toward personalized medicine, allowing more fetuses to benefit from fetal surgery than would have benefitted with the former, published, MOMS criteria in place.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningomyeloceleSpinal DysraphismSpina Bifida CysticaPregnancyHumansFemaleInfantMalePrecision MedicineFetusPrenatal CareGestational Age

Stichwörter der Autor:innen

MOMS criteriaMaternal fetal surgeryMyelomeningocele

Autor:innen und Institutionen

  • Department of Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.
  • The Zurich Center for Fetal Diagnosis and Therapy, University of Zurich, Zurich, Switzerland.
  • Children's Research Center (CRC), University Children's Hospital Zurich, Zurich, Switzerland.
  • Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Spina Bifida Academy, University Children's Hospital and University Hospital Zurich, Zurich, Switzerland.
  • Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland.

Zitieren

APA

Moehrlen, U., Ochsenbein-Kölble, N., Stricker, S., Moehrlen, T., Mazzone, L., Krähenmann, F., Vonzun, L., Zimmermann, R., Spina Bifida Study Group Zurich, & Meuli, M. (2023). Prenatal Spina Bifida Repair: Defendable Trespassing of MOMS Criteria Results in Commendable Personalized Medicine. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000533181

Vancouver

Moehrlen U, Ochsenbein-Kölble N, Stricker S, Moehrlen T, Mazzone L, Krähenmann F, et al. Prenatal Spina Bifida Repair: Defendable Trespassing of MOMS Criteria Results in Commendable Personalized Medicine. Fetal Diagnosis and Therapy. 2023. doi:10.1159/000533181

BibTeX
@article{Moehrlen2023,
  author = {Moehrlen, Ueli and Ochsenbein-Kölble, Nicole and Stricker, Sarah and Moehrlen, Theres and Mazzone, Luca and Krähenmann, Franziska and Vonzun, Ladina and Zimmermann, Roland and Spina Bifida Study Group Zurich, Spina Bifida Study Group Zurich and Meuli, Martin},
  title = {Prenatal Spina Bifida Repair: Defendable Trespassing of MOMS Criteria Results in Commendable Personalized Medicine},
  journal = {Fetal Diagnosis and Therapy},
  year = {2023},
  doi = {10.1159/000533181}
}
Kostenlos starten →